TY - JOUR
T1 - Guidelines for Infection Control in the Urological Field, including Urinary Tract Management (revised second edition)
AU - Takahashi, Satoshi
AU - Arakawa, Soichi
AU - Ishikawa, Kiyohito
AU - Kamei, Jun
AU - Kobayashi, Kanao
AU - Shigemura, K.
AU - Takahashi, Satoru
AU - Hiyama, Yoshiki
AU - Hamasuna, Ryoichi
AU - Hayami, Hiroshi
AU - Yazawa, Satoshi
AU - Yasuda, Mitsuru
AU - Togo, Yoshikazu
AU - Yamamoto, Shingo
AU - Wada, Koichiro
AU - Watanabe, Toyohiko
N1 - Funding Information:
Satoshi Takahashi received speaker honoraria from MSD K.K. and research grants from Shino‐Test Corporation, Fujirebio Inc., Roche Diagnostics K.K., and Abbott Japan Co., Ltd. Kiyohito Ishikawa received speaker honoraria from MSD K.K. and research grants from KYORIN Medical Supply Co., Ltd. Soichi Arakawa received speaker honoraria from MSD K.K. Satoru Takahashi received honoraria as a speaker from Pfizer, Astellas, Kissei and Ferring in 2020 and 2021. Ryoichi Hamasuna had collaborative projects with Daiichi Sankyo RD, Novare Co. Ltd., Hologic Japan Inc. and Mizuho Medy Co. Ltd. Koichiro Wada received speaker honoraria from MSD K.K., Kyowa Kirin Co., Ltd. and Saitama City Foundation for Business Creation.
Publisher Copyright:
© 2021 The Japanese Urological Association
PY - 2021/12
Y1 - 2021/12
N2 - The Committee for the Development of Guidelines for Infection Control in the Urological Field, including Urinary Tract Management of the Japanese Urological Association, together with its systematic review team and external reviewers, have prepared a set of practice guidelines, an abridged version of which is published herein. These guidelines cover the following topics: (i) foundations of infection control, standard precautions, route-specific precautions, and occupational infection control (including vaccines); (ii) the relationship between urologists and infection control; (iii) infection control in urological wards and outpatient clinics; (iv) response to hepatitis B virus reactivation; (v) infection control in urological procedures and examinations; (vi) prevention of infections occurring in conjunction with medical procedures and examinations; (vii) responses to urinary tract tuberculosis and bacillus Calmette–Guérin; (viii) aseptic handling, cleaning, disinfection, and sterilization of urinary tract endoscopes (principles of endoscope manipulation, endoscope lumen cleaning, and disinfection); (ix) infection control in the operating room (principles of hand washing, preoperative rubbing methods, etc.); (x) prevention of needlestick and blood/bodily fluid exposure and response to accidental exposure; (xi) urinary catheter-associated urinary tract infection and purple urinary bag syndrome; and (xii) urinary catheter-associated urinary tract infections in conjunction with home care. In addressing these topics, the relevant medical literature was searched to the extent possible, and content was prepared for the purpose of providing useful information for clinical practice.
AB - The Committee for the Development of Guidelines for Infection Control in the Urological Field, including Urinary Tract Management of the Japanese Urological Association, together with its systematic review team and external reviewers, have prepared a set of practice guidelines, an abridged version of which is published herein. These guidelines cover the following topics: (i) foundations of infection control, standard precautions, route-specific precautions, and occupational infection control (including vaccines); (ii) the relationship between urologists and infection control; (iii) infection control in urological wards and outpatient clinics; (iv) response to hepatitis B virus reactivation; (v) infection control in urological procedures and examinations; (vi) prevention of infections occurring in conjunction with medical procedures and examinations; (vii) responses to urinary tract tuberculosis and bacillus Calmette–Guérin; (viii) aseptic handling, cleaning, disinfection, and sterilization of urinary tract endoscopes (principles of endoscope manipulation, endoscope lumen cleaning, and disinfection); (ix) infection control in the operating room (principles of hand washing, preoperative rubbing methods, etc.); (x) prevention of needlestick and blood/bodily fluid exposure and response to accidental exposure; (xi) urinary catheter-associated urinary tract infection and purple urinary bag syndrome; and (xii) urinary catheter-associated urinary tract infections in conjunction with home care. In addressing these topics, the relevant medical literature was searched to the extent possible, and content was prepared for the purpose of providing useful information for clinical practice.
KW - infection control
KW - urinary tract infection
KW - urology
UR - http://www.scopus.com/inward/record.url?scp=85114469333&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114469333&partnerID=8YFLogxK
U2 - 10.1111/iju.14684
DO - 10.1111/iju.14684
M3 - Comment/debate
C2 - 34480379
AN - SCOPUS:85114469333
SN - 0919-8172
VL - 28
SP - 1198
EP - 1211
JO - International Journal of Urology
JF - International Journal of Urology
IS - 12
ER -